Literature DB >> 9109408

Characterization and receptor specific toxicity of two diphtheria toxin-related interleukin-3 fusion proteins DAB389-mIL-3 and DAB389-(Gly4Ser)2-mIL-3.

D Liger1, J C vanderSpek, C Gaillard, C Cansier, J R Murphy, P Leboulch, D Gillet.   

Abstract

We have constructed two fusion proteins, DAB389-mIL-3 and DAB389-(Gly4Ser)2-mIL-3, in which the receptor-binding domain of diphtheria toxin is replaced by mouse interleukin-3 (IL-3). Cytotoxic activity of the fusion toxins was observed on three out of six cell lines assayed. This toxicity was mediated through binding to the IL-3 receptor as it was inhibited in a dose-dependent manner with murine IL-3 or anti-IL-3 neutralizing antibodies. DAB389-(Gly4Ser)2-mIL-3 was up to 5 times more toxic than DAB389-mIL-3, depending on the cell line (0.8 x 10(-10) M < IC50 < 3 x 10(-10) M). These proteins can be used for the detection of IL-3 receptors on mouse cells and should allow for the selective elimination of IL-3 receptor-positive pluripotent hematopoietic stem cells prior to bone marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9109408     DOI: 10.1016/s0014-5793(97)00243-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Development without germ cells: the role of the germ line in zebrafish sex differentiation.

Authors:  Krasimir Slanchev; Jürg Stebler; Guillermo de la Cueva-Méndez; Erez Raz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-23       Impact factor: 11.205

2.  Targeting head and neck squamous cell carcinoma using a novel fusion toxin-diphtheria toxin/HN-1.

Authors:  Sirisha Potala; Rama S Verma
Journal:  Mol Biol Rep       Date:  2010-08-01       Impact factor: 2.316

3.  A New Combination: Anti Glypican-3 scFv and Diphtheria Toxin with the Best Flexible Linker.

Authors:  Hamid Hashemi Yeganeh; Mohammad Heiat; Seyed Moayed Alavian; Ehsan Rezaei
Journal:  Protein J       Date:  2022-08-24       Impact factor: 4.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.